The effect of high mobility group box-1 protein on immune function of human T lymphocytes in vitro

Chinese Critical Care Medicine

Volumn 20, Issue 1, 2008, Pages 7-13

  Huang, Li Feng ^a   Yao, Yong Ming ^a   Meng, Hai Dong ^a   Zhao, Xiao Dong ^a   Dong, Ning ^a   Yu, Yan ^a   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

High mobility group box 1 protein; Immunity; Interleukin 2; Proliferation; T lymphocytes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; RECOMBINANT PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION; VOLUNTEER;

ADOLESCENT; ADULT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; RECOMBINANT PROTEINS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 39049133908     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Goodwin G H, Johns E W. Isolation and characterisation of two calf-thymus chromatin non-histone proteins with high contents of acidic and basic amino acids [J]. Eur J Biochem, 1973, 40(1): 215-219.
2. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice [J]. Science, 1999, 285(5425): 248-251.
3. Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine [J]. Clin Chim Acta, 2007, 375(1-2): 36-42.
4. Liu H, Yao Y M, Yu Y, et al. Role of janus kinase/signal transducer and activator of transcription pathway in regulation of expression and inflammation-promoting activity of high mobility group box protein 1 in rat peritoneal macrophages [J]. Shock, 2007, 27(1): 55-60.
5. Dong N, Yao Y M, Yu Y, et al. Changes in plasma high mobility group box-1 protein levels and its relationship with sepsis in severely burned patients [J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2007, 29(4): 466-470. (in Chinese)
6. Kokkola R, Sundberg E, Ulfgren AK, et al. High mobility group box chromosomal protein l: a novel proinflammatory mediator in synovitis[J]. Arthritis Rheum, 2002, 46(10): 2598-2603.
7. Wang Z, Larregina A T, Shufesky W J, et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells [J]. Am J Transplant, 2006, 6(6): 1297-1311.
8. Cao Y X, Jin B Q, Han W N. Application of CD3/CD8 gating to examination of Th1/Th2 cells in flow cytometry[J]. J Cell Mol Immunol, 2002, 18(6): 638-639.
9. David D, Bani L, Moreau J L, et al. Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets [J]. Blood, 1998, 91 (1): 165-172.
10. Breen E C, McDonald M, Fan J, et al. Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons [J]. Clin Diagn Lab Immunol, 2000, 7(5): 769-773.
11. Angus D C, Linde-Zwirble W T, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [J]. Crit Care Med, 2001, 29(7): 1303-1310.
12. Danai P, Martin G S. Epidemiology of sepsis:recent advances [J]. Curr Infect Dis Rep, 2005, 7(5): 329-334.
13. Fang W H, Yao Y M, Shi Z G, et al. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J]. Shock, 2002, 17(4): 329-333.
14. Yao Y M, Liu H. Updated understanding of high mobility group box 1 protein in sepsis [J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2005, 17(7): 385-387. (in Chinese)
15. + T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis [J]. Invest Ophthalmol Vis Sci, 2001, 42(6): 1285-1292.
16. Inui N, Chida K, Suda T, et al. TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis [J]. J Allergy Clin Immunol, 2001, 107(2): 337-344.
17. Dong Y Q, Yao Y M, Wei P, et al. Effects of ethyl pyruvate on cell-mediated immune function in rats with delayed resuscitation after burn injury[J]. Zhonaguo Wei Zhong Bing Ji Jiu Yi Xue, 2005, 17(1): 12-15. (in Chinese)
18. Hörner C, Bouchon A, Bierhaus A, et al. Role of the innate immune response in sepsis [J]. Anaesthesist, 2004, 53(1): 10-28.
19. Yao Y M. Host immunosuppression in pathogenesis of sepsis and its clinical implication [J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2007, 19(3): 138-141. (in Chinese)
20. Pachot A, Monneret G, Voirin N, et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock [J]. Clin Immunol, 2005, 114(1): 61-69.
21. Cabioglu N, Bilgic S, Deniz G, et al. Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis[J]. Arch Surg, 2002, 137(9): 1037-1043.